Global Influenza Medication Market Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Influenza Medication industries have also been greatly affected.
In the past few years, the Influenza Medication market experienced a growth of 7, the global market size of Influenza Medication reached (2020 Market size XXXX) million $ in 2020, of what is about (2015 Market size XXXX) million $ in 2015.
From 2015 to 2019, the growth rate of global Influenza Medication market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Influenza Medication market size in 2020 will be (2020 Market size XXXX) with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Influenza Medication market size will reach (2025 Market size XXXX) million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Daiichi Sankyo Company
GlaxoSmithKline plc
Natco Pharma
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries Ltd.
Mylan Inc.
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Industry Segmentation
Hospitals
Clinics
Pharmacies
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Influenza Medication Product Definition
Section 2 Global Influenza Medication Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Influenza Medication Shipments
2.2 Global Manufacturer Influenza Medication Business Revenue
2.3 Global Influenza Medication Market Overview
2.4 COVID-19 Impact on Influenza Medication Industry
Section 3 Manufacturer Influenza Medication Business Introduction
3.1 Daiichi Sankyo Company Influenza Medication Business Introduction
3.1.1 Daiichi Sankyo Company Influenza Medication Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Daiichi Sankyo Company Influenza Medication Business Distribution by Region
3.1.3 Daiichi Sankyo Company Interview Record
3.1.4 Daiichi Sankyo Company Influenza Medication Business Profile
3.1.5 Daiichi Sankyo Company Influenza Medication Product Specification
3.2 GlaxoSmithKline plc Influenza Medication Business Introduction
3.2.1 GlaxoSmithKline plc Influenza Medication Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 GlaxoSmithKline plc Influenza Medication Business Distribution by Region
3.2.3 Interview Record
3.2.4 GlaxoSmithKline plc Influenza Medication Business Overview
3.2.5 GlaxoSmithKline plc Influenza Medication Product Specification
3.3 Natco Pharma Influenza Medication Business Introduction
3.3.1 Natco Pharma Influenza Medication Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Natco Pharma Influenza Medication Business Distribution by Region
3.3.3 Interview Record
3.3.4 Natco Pharma Influenza Medication Business Overview
3.3.5 Natco Pharma Influenza Medication Product Specification
3.4 F. Hoffmann-La Roche Ltd. Influenza Medication Business Introduction
3.5 Teva Pharmaceutical Industries Ltd. Influenza Medication Business Introduction
3.6 Sandoz International GmbH (Novartis AG) Influenza Medication Business Introduction
…
Section 4 Global Influenza Medication Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Influenza Medication Market Size and Price Analysis 2015-2020
4.1.2 Canada Influenza Medication Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Influenza Medication Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Influenza Medication Market Size and Price Analysis 2015-2020
4.3.2 Japan Influenza Medication Market Size and Price Analysis 2015-2020
4.3.3 India Influenza Medication Market Size and Price Analysis 2015-2020
4.3.4 Korea Influenza Medication Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Influenza Medication Market Size and Price Analysis 2015-2020
4.4.2 UK Influenza Medication Market Size and Price Analysis 2015-2020
4.4.3 France Influenza Medication Market Size and Price Analysis 2015-2020
4.4.4 Italy Influenza Medication Market Size and Price Analysis 2015-2020
4.4.5 Europe Influenza Medication Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Influenza Medication Market Size and Price Analysis 2015-2020
4.5.2 Africa Influenza Medication Market Size and Price Analysis 2015-2020
4.5.3 GCC Influenza Medication Market Size and Price Analysis 2015-2020
4.6 Global Influenza Medication Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Influenza Medication Market Segmentation (Region Level) Analysis
Section 5 Global Influenza Medication Market Segmentation (Product Type Level)
5.1 Global Influenza Medication Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Influenza Medication Product Type Price 2015-2020
5.3 Global Influenza Medication Market Segmentation (Product Type Level) Analysis
Section 6 Global Influenza Medication Market Segmentation (Industry Level)
6.1 Global Influenza Medication Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Influenza Medication Market Segmentation (Industry Level) Analysis
Section 7 Global Influenza Medication Market Segmentation (Channel Level)
7.1 Global Influenza Medication Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Influenza Medication Market Segmentation (Channel Level) Analysis
Section 8 Influenza Medication Market Forecast 2020-2025
8.1 Influenza Medication Segmentation Market Forecast (Region Level)
8.2 Influenza Medication Segmentation Market Forecast (Product Type Level)
8.3 Influenza Medication Segmentation Market Forecast (Industry Level)
8.4 Influenza Medication Segmentation Market Forecast (Channel Level)
Section 9 Influenza Medication Segmentation Product Type
9.1 Zanamivir Product Introduction
9.2 Oseltamivir Product Introduction
9.3 Peramivir Product Introduction
9.4 Amantadine Product Introduction
9.5 Rimantadine Product Introduction
Section 10 Influenza Medication Segmentation Industry
10.1 Hospitals Clients
10.2 Clinics Clients
10.3 Pharmacies Clients
Section 11 Influenza Medication Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Influenza Medication Product Picture from Daiichi Sankyo Company
Chart 2015-2020 Global Manufacturer Influenza Medication Shipments (Units)
Chart 2015-2020 Global Manufacturer Influenza Medication Shipments Share
Chart 2015-2020 Global Manufacturer Influenza Medication Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Influenza Medication Business Revenue Share
Chart Daiichi Sankyo Company Influenza Medication Shipments, Price, Revenue and Gross profit 2015-2020
Chart Daiichi Sankyo Company Influenza Medication Business Distribution
Chart Daiichi Sankyo Company Interview Record (Partly)
Figure Daiichi Sankyo Company Influenza Medication Product Picture
Chart Daiichi Sankyo Company Influenza Medication Business Profile
Table Daiichi Sankyo Company Influenza Medication Product Specification
Chart GlaxoSmithKline plc Influenza Medication Shipments, Price, Revenue and Gross profit 2015-2020
Chart GlaxoSmithKline plc Influenza Medication Business Distribution
Chart GlaxoSmithKline plc Interview Record (Partly)
Figure GlaxoSmithKline plc Influenza Medication Product Picture
Chart GlaxoSmithKline plc Influenza Medication Business Overview
Table GlaxoSmithKline plc Influenza Medication Product Specification
Chart Natco Pharma Influenza Medication Shipments, Price, Revenue and Gross profit 2015-2020
Chart Natco Pharma Influenza Medication Business Distribution
Chart Natco Pharma Interview Record (Partly)
Figure Natco Pharma Influenza Medication Product Picture
Chart Natco Pharma Influenza Medication Business Overview
Table Natco Pharma Influenza Medication Product Specification
3.4 F. Hoffmann-La Roche Ltd. Influenza Medication Business Introduction
…
Chart United States Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Canada Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Influenza Medication Sales Price ($/Unit) 2015-2020
Chart South America Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Influenza Medication Sales Price ($/Unit) 2015-2020
Chart China Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Japan Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Influenza Medication Sales Price ($/Unit) 2015-2020
Chart India Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Korea Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Germany Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Influenza Medication Sales Price ($/Unit) 2015-2020
Chart UK Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Influenza Medication Sales Price ($/Unit) 2015-2020
Chart France Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Italy Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Europe Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Middle East Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Africa Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Influenza Medication Sales Price ($/Unit) 2015-2020
Chart GCC Influenza Medication Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Influenza Medication Sales Price ($/Unit) 2015-2020
Chart Global Influenza Medication Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Influenza Medication Market Segmentation (Region Level) Market size 2015-2020
Chart Influenza Medication Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Influenza Medication Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Influenza Medication Product Type Price ($/Unit) 2015-2020
Chart Influenza Medication Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Influenza Medication Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Influenza Medication Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Influenza Medication Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Influenza Medication Market Segmentation (Channel Level) Share 2015-2020
Chart Influenza Medication Segmentation Market Forecast (Region Level) 2020-2025
Chart Influenza Medication Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Influenza Medication Segmentation Market Forecast (Industry Level) 2020-2025
Chart Influenza Medication Segmentation Market Forecast (Channel Level) 2020-2025
Chart Zanamivir Product Figure
Chart Zanamivir Product Advantage and Disadvantage Comparison
Chart Oseltamivir Product Figure
Chart Oseltamivir Product Advantage and Disadvantage Comparison
Chart Peramivir Product Figure
Chart Peramivir Product Advantage and Disadvantage Comparison
Chart Amantadine Product Figure
Chart Amantadine Product Advantage and Disadvantage Comparison
Chart Rimantadine Product Figure
Chart Rimantadine Product Advantage and Disadvantage Comparison
Chart Hospitals Clients
Chart Clinics Clients
Chart Pharmacies Clients
Research Methodology:
Influenza Medication Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|